共 50 条
- [1] Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors? JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
- [2] Therapy of the metastatic Merkel Cell Carcinoma with the Anti-PD-1 Antibody Pembrolizumab JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 171 - 171
- [3] PD-1 Blockade as a therapeutic Option for metastatic Merkel Cell Carcinoma JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 12 - 13
- [5] Myasthenia gravis induced by pembrolizumab in a patient with metastatic Merkel cell carcinoma ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2022, 149 (02): : 142 - 145
- [6] Myasthenia gravis-like Myopathy in metastatic cutaneous Squamous Cell Carcinoma under Anti-PD-1 Therapy JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 75 - 75
- [7] Response to Anti-PD-1 Therapy in Metastatic Merkel Cell Carcinoma Metastatic to the Heart and Pancreas CUREUS, 2015, 7 (12):
- [8] Outcome of patient with myasthenia gravis with the use of immunotherapy in metastatic Merkel cell carcinoma OXFORD MEDICAL CASE REPORTS, 2022, 2022 (02): : 67 - 70